Cellid Co. Ltd (299660) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.047x

Based on the latest financial reports, Cellid Co. Ltd (299660) has a cash flow conversion efficiency ratio of -0.047x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.71 Billion ≈ $-2.51 Million USD) by net assets (₩78.71 Billion ≈ $53.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cellid Co. Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Cellid Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Cellid Co. Ltd total liabilities for a breakdown of total debt and financial obligations.

Cellid Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cellid Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Makarony Polskie S.A. WAR:MAK	0.030x
Beijing North Star Company Limited F:BJ3	0.076x
A SPAC II Acquisition Corp. Ordinary Shares NASDAQ:ASCB	0.036x
Brompton Lifeco Split Corp TO:LCS	-0.011x
Thermaltake Technology Co Ltd TWO:3540	-0.104x
OnMobile Global Limited NSE:ONMOBILE	0.086x
Ilji Technology Co. Ltd KQ:019540	0.067x
Chemfab Alkalis Limited NSE:CHEMFAB	0.030x

Annual Cash Flow Conversion Efficiency for Cellid Co. Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Cellid Co. Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Cellid Co. Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩51.20 Billion ≈ $34.70 Million	₩-10.32 Billion ≈ $-6.99 Million	-0.201x	-14.66%
2023-12-31	₩40.50 Billion ≈ $27.44 Million	₩-7.12 Billion ≈ $-4.82 Million	-0.176x	+67.73%
2022-12-31	₩22.44 Billion ≈ $15.21 Million	₩-12.22 Billion ≈ $-8.28 Million	-0.544x	-157.14%
2021-12-31	₩38.76 Billion ≈ $26.27 Million	₩-8.21 Billion ≈ $-5.56 Million	-0.212x	-166.09%
2020-12-31	₩47.30 Billion ≈ $32.05 Million	₩-3.76 Billion ≈ $-2.55 Million	-0.080x	-112.62%
2019-12-31	₩51.33 Billion ≈ $34.79 Million	₩-1.92 Billion ≈ $-1.30 Million	-0.037x	+74.67%
2018-12-31	₩13.50 Billion ≈ $9.15 Million	₩-1.99 Billion ≈ $-1.35 Million	-0.148x	-159.53%
2017-12-31	₩-5.53 Billion ≈ $-3.75 Million	₩-1.37 Billion ≈ $-929.53K	0.248x	-96.60%
2016-12-31	₩-205.83 Million ≈ $-139.49K	₩-1.50 Billion ≈ $-1.02 Million	7.306x	--

About Cellid Co. Ltd

KQ:299660 Korea Biotechnology

Market Cap

$63.58 Million

₩93.82 Billion KRW

Market Cap Rank

#20952 Global

#1292 in Korea

Share Price

₩3180.00

Change (1 day)

-1.55%

52-Week Range

₩2315.00 - ₩8890.00

All Time High

₩127128.20